Fund shareholders of Opus Genetics Inc
ISIN US67577R1023 · United States · LEI 529900C85NBMQFSETD92
- Fund shareholders
- 10
- Of which ETFs
- 0 10 other funds
- Value held
- 13M $
- Share of capital
- 3.5 % of 83.2M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,894,478 | 8.6M $ | 0.00 % | 2.28 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 471,989 | 2.1M $ | 0.00 % | 0.57 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 229,160 | 953.3K $ | 0.00 % | 0.28 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 95,002 | 395.2K $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 68,321 | 284.2K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 38,271 | 174.1K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 35,000 | 178.9K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 29,775 | 123.9K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 26,271 | 119.5K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 5,939 | 30.3K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 10 | 0 | 2,894,206 | +18.8 % |
| 2026Q1 | 10 | +2 | 2,436,942 | +68.1 % |
| 2025Q4 | 8 | +1 | 1,449,277 | +12.3 % |
| 2025Q3 | 7 | -4 | 1,291,003 | -8.0 % |
| 2025Q2 | 11 | -1 | 1,403,675 | +2.3 % |
| 2025Q1 | 12 | -1 | 1,372,458 | -5.6 % |
| 2024Q4 | 13 | -4 | 1,454,273 | -2.7 % |
| 2024Q3 | 17 | -1 | 1,495,012 | -5.2 % |
| 2024Q2 | 18 | -1 | 1,576,832 | +1.2 % |
| 2024Q1 | 19 | -3 | 1,558,666 | +13.3 % |
| 2023Q4 | 22 | 1,375,123 |
Institutional managers
75 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Caligan Partners LP | 6,075,028 | 27.6M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,029,775 | 27.4M $ | as of Mar 31, 2026 |
| BIOS Capital Management, LP | 3,683,429 | 16.8M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 2,718,029 | 12.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,630,432 | 12M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,313,380 | 10.5M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 2,250,000 | 10.2M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,849,004 | 8.4M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,835,842 | 8.4M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 1,681,330 | 7.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 1,354,030 | 6.2M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,189,113 | 5.4M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 1,120,000 | 2.3M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | 4.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 823,383 | 3.7M $ | as of Mar 31, 2026 |
| Bleichroeder LP | 736,842 | 3.4M $ | as of Mar 31, 2026 |
| Mink Brook Asset Management LLC | 590,552 | 2.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 538,347 | 2.5M $ | as of Mar 31, 2026 |
| Trails Edge Capital Partners, LP | 500,000 | 2.3M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 388,491 | 1.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 326,809 | 1.5M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 324,340 | 1.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 257,649 | 1.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 199,953 | 909.8K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 158,103 | 719.4K $ | as of Mar 31, 2026 |
Declared shareholders of Opus Genetics Inc
7 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Perceptive Advisors LLC and 2 others | 9.99 % | 8,830,145 | as of Mar 31, 2026 · SCHEDULE 13G |
| Caligan Partners LP and 1 other | 8.50 % | 6,075,028 | as of Mar 31, 2026 · SCHEDULE 13G |
| Adage Capital Management, L.P. and 2 others | 8.47 % | 6,029,775 | as of Mar 31, 2026 · SCHEDULE 13G |
| Balyasny Asset Management L.P. and 4 others | 7.18 % | 5,110,373 | as of Mar 31, 2026 · SCHEDULE 13G |
| Nantahala Capital Management, LLC and 2 others | 6.51 % | 4,839,225 | as of Mar 31, 2026 · SCHEDULE 13G |
| Foundation Fighting Blindness Retinal Degeneration Fund and 1 other | 4.66 % | 3,792,171 | as of May 18, 2026 · SCHEDULE 13D |
| AARON G.L. FLETCHER and 9 others | 4.53 % | 3,683,429 | as of May 12, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Opus Genetics Inc". https://titelia.com/en/stocks/opus-genetics-inc-US67577R1023